LGNDLigand Pharmaceuticals Incorporated
286.29USD-1.52%Mkt Cap: 5.71B $P/E: 29.483d ago
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap5.71B $
Enterprise Value5.50B $
Revenue (TTM)290.54M $
Gross Profit253.54M $
Net Income (TTM)124.45M $
Revenue/Share14.75 USD
Last Price286.29 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS53220K5048
Valuation
P/E (Trailing)29.48
P/E (Forward)24.08
PEG1.53
EV/EBITDA41.37
EV/Revenue18.94
P/S19.72
P/B5.92
EPS (TTM)9.60
EPS (Forward)11.93
52W Range
149.5179% of range323.33
52W High323.33 USD
52W Low149.51 USD
Profitability
Gross Margin94.57%
Oper. Margin13.49%
EBITDA Margin45.78%
Profit Margin46.42%
ROE12.23%
ROA7.97%
Growth
Revenue Growth33.70%
Earnings Growth825.00%
Cash Flow & Leverage
Operating CF49.36M $
CapEx (TTM)11.31M $
FCF Margin48.10%
FCF Yield2.45%
Net Debt-226.30M $
Net Debt/EBITDA-1.70
Balance Sheet
Debt/Equity0.44
Current Ratio31.18
Quick Ratio30.83
Book Value/Sh48.57 USD
Cash/Share68.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 2, 2010
Pay Date—
Splits
Last Split1603:1000
Split DateNov 2, 2022
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)342.82 USD
Upside (mean)+19.7%
Target Range247.00 USD – 390.00 USD
$247.00+19.7% to mean$390.00
# Analysts11
Ownership
Shares Out.19.94M
Float19.48M
Insiders2.38%
Institutions116.17%
Short Interest
Short Ratio6.0d
Short % Float13.06%
Short % Out.10.89%
Shares Short2.17M
Short (prev mo.)2.12M
Technical
SMA 50293.44 (-2.4%)
SMA 200227.78 (+25.7%)
Beta0.98
S&P 52W Chg18.16%
Avg Vol (30d)267.79K
Avg Vol (10d)247.01K
Technical Indicators
RSI (14)44.7
MACD-0.5926
MACD Signal0.9989
MACD Hist.-1.5915
BB Upper304.63 USD
BB Middle294.34 USD
BB Lower284.06 USD
BB Width6.99%
ATR (14)10.49 USD
Vol Ratio (20d)0.55x